Macrolide Pharmaceuticals picks up $22 mln

By Iris Dorbian — 9 months ago

Newton, Massachusetts-based Macrolide Pharmaceuticals, a new company focused on developing novel antibiotics, has secured $22 million in Series A funding. The investors were Novartis Venture Fund, Gurnet Point Capital, Roche Ventures, and SROne.


Principia Biopharma Inks $12.5M

By Staff Report — 3 years ago

Principia Biopharma Inc., a biopharmaceutical company focused on immunology, autoimmune diseases, and oncology, has raised $12.5 million. Investors include New Leaf Venture Partners, OrbiMed Advisors, Morgenthaler Ventures, SROne and Mission Bay Capital.